4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0002034671-25-000012
Chief Executive Officer acquired 29,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mazumdar Claire Chief Executive Officer | 2025-12-16 | Option exercise | +29,500 | $5.45 | $160,884 | 339,392 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Mazumdar Claire Chief Executive Officer | 2025-12-16 | Option exercise · Stock Option (Right to Buy) | −29,500 | 565,512 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1766098974.xml…